Literature DB >> 84062

Serotonin metabolism with idiopathic grand mal seizures.

D R Matz, L H Rolf, G G Brune.   

Abstract

Serotonin was determined in platelets of 140 patients with idiopathic mal seizures. According to anticonvulsive therapy these patients were divided into the following five groups: no medication, Diphenylhydantoin, Diphenylhydantoin calcium, Primidon, and combination of various of the anticonvulsants mentioned. The results obtained in the entire group of patients as well as in the various subgroups were compared with those of a group of healthy persons without therapy. In addition the various subgroups were compared to each other. There were significantly reduced serotonin values in the patients with idiopathic grand mal seizures as well as in each of its various groups as compared with the values obtained in healthy persons. Furthermore, significantly higher values were observed in the patients receiving primidone as compared with those receiving no anticonvulsants, Diphenylhydantoin, and a combination of various anticonvulsants. Our results taken together with those reported in the literature point to the possibility that a special imbalance in the cerebral neurotransmitter system, including a deficiency of serotonin, may represent a pathogenetic factor for idiopathic grand mal seizures. In addition, this investigation indicates that primidone elevates serotonin in platelets of patients with grand mal seizures.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 84062     DOI: 10.1007/BF00312982

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  16 in total

1.  Relationship of platelet serotonin to disturbances of clotting and hemostasis.

Authors:  M WEINER; S UDENFRIEND
Journal:  Circulation       Date:  1957-03       Impact factor: 29.690

2.  Acetylcholine synthesis in different regions of the central nervous system.

Authors:  W Feldberg; M Vogt
Journal:  J Physiol       Date:  1948-06-25       Impact factor: 5.182

3.  A facilitation action of reserpine on the central nervous system.

Authors:  G CHEN; C R ENSOR; B BOHNER
Journal:  Proc Soc Exp Biol Med       Date:  1954-07

4.  Effect of anticonvulsants on brain serotonin.

Authors:  T N Chase; R I Katz; I J Kopin
Journal:  Trans Am Neurol Assoc       Date:  1969

5.  Reduced cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in children with epilepsy.

Authors:  B A Shaywitz; D J Cohen; M B Bowers
Journal:  Neurology       Date:  1975-01       Impact factor: 9.910

6.  [Distribution of 5-hydroxytryptamine (serotonin) in the human brain and its behavior in patients with Parkinson's syndrome].

Authors:  H BERNHEIMER; W BIRKMAYER; O HORNYKIEWICZ
Journal:  Klin Wochenschr       Date:  1961-10-15

7.  Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects.

Authors:  D A Curran; H Hinterberger; J W Lance
Journal:  Brain       Date:  1965-12       Impact factor: 13.501

8.  Anticonvulsant compounds and 5-hydroxytryptamine in rat brain.

Authors:  D D BONNYCASTLE; N J GIARMAN; M K PAASONEN
Journal:  Br J Pharmacol Chemother       Date:  1957-06

9.  Studies on the 5-hydroxytryptamine (serotonin) content in human brain.

Authors:  E COSTA; M H APRISON
Journal:  J Nerv Ment Dis       Date:  1958-03       Impact factor: 2.254

10.  [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].

Authors:  H EHRINGER; O HORNYKIEWICZ
Journal:  Klin Wochenschr       Date:  1960-12-15
View more
  3 in total

1.  Brain 5-hydroxytryptamine level, metabolism, and binding in E1 mice.

Authors:  M Hiramatsu
Journal:  Neurochem Res       Date:  1983-09       Impact factor: 3.996

2.  Challenges in a large mixed drug overdose patient.

Authors:  Paige Zhang; Emily Austin; Margaret Thompson; Steve Lin
Journal:  BMJ Case Rep       Date:  2016-06-22

3.  TAK-733 inhibits inflammatory neointimal formation by suppressing proliferation, migration, and inflammation in vitro and in vivo.

Authors:  Jun-Hee Park; Sang Woo Kim; Min-Ji Cha; Nara Yoon; Chang Youn Lee; Jiyun Lee; Hyang-Hee Seo; Sunhye Shin; Jung-Won Choi; Seahyoung Lee; Soyeon Lim; Ki-Chul Hwang
Journal:  Exp Mol Med       Date:  2018-04-20       Impact factor: 8.718

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.